Loading...

Skip Navigation LinksHome > Support Groups > Discussion Messages
Miscellaneous :
General

This support group serves as an information center for other discussions on health topics.

 

Join this Group


 











Loading...

News Comments
Add a topic Recent discussions
Start watching this topic
New Alerts Needed for ADHD drugs

Most attention deficit hyperactivity disorder drugs should include new warnings about the risk of psychotic behavior, heart problems and sudden death, according to U.S. health...Read More

Posted on : Tuesday, August 22, 2006 12:00 AM
Add reply       No of replies : 1

Report Abuse

You can help us in removing abusive content or spam.
Your Name
Your Email ID
Subject
Message
(Maximum 3000 Characters)
  
 

Guest

I took zyprexa which was ineffective for my condition and gave me diabetes.

Zyprexa, which is used for the treatment of psychiatric disorders, such as schizophrenia and bipolar disorder, accounted for 32% of Eli Lilly's $14.6 billion revenue last year.

Zyprexa is the product name for Olanzapine,it is Lilly's top selling drug.It was approved by the FDA in 1996 ,an 'atypical' antipsychotic a newer class of drugs without the motor side effects of the older Thorazine.Zyprexa has been linked to causing diabetes and pancreatitis.

Did you know that Lilly made nearly $3 billion last year on diabetic meds, Actos,Humulin and Byetta?

Yes! They sell a drug that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place!

I was prescribed Zyprexa from 1996 until 2000.
In early 2000 i was shocked to have an A1C test result of 13.9 (normal is 4-6) I have no history of diabetes in my family.
----
Daniel Haszard http://www.zyprexa-victims.com
Replied on Tuesday, August 22, 2006 12:00 AM
 


Member Sign In

Remember me
Forgot Password?
Sign up now


Medwonders has 257228 Members and 444 Groups.
Last Updated - Nov 22, 2024 - Designed & Content Managed by Medindia4u.com Pvt. Ltd.
Copyright © 2024 Medindia4u.com Pvt. Ltd. All rights reserved.